Issue #10 June 2021
atcormedical.com • 2 minute read

Welcome to VITALITY.

You’re receiving this newsletter because you’re a customer, partner, or you’ve otherwise subscribed or opted in at one of our events, conferences, or website. 

Summary:

• Note from our CEO, Craig Cooper.
• CONNEQT & LifeQ partner.
• Yale University to use ATCOR XCEL SphygmoCor in trial.
• New US patents for PPG sensors.

As the summer continues to heat up, we are excited to share new partnerships, new patent applications and new research projects. Last week we announced a new partnership in innovation with LifeQ to power the CONNEQT Band — a disruptive and innovative new health wearable. CardieX also announced new health sensor patent applications to cover gaming, computer devices, and other electronic hardware.

CardieX subsidiary, ATCOR’s SphygmoCor® XCEL System was also recently selected to for an important clinical trial at Yale University focused on maternal health.

Stay healthy, stay strong,

CardieX’s consumer brand CONNEQT, announced a Collaborative Agreement to leverage each company’s IP for the CONNEQT Band, expected to be the world’s first AI-powered, FDA cleared, clinical grade smart health band with dual-PPG sensing tech.

For details on the partnership, check out CardieX CEO, Craig Cooper’s interview with Proactive Investors. Follow CONNEQT on Twitter or Instagram for updates.

Hypertension during pregnancy is a cause of maternal morbidity in 6.5% of women, but is preventable. To better understand and prevent this dangerous condition, Yale University’s ASPPIRE trial is using ATCOR’s SphygmoCor® XCEL System to measure central blood pressure in its study of aspirin to prevent pre-eclampsia. For more, click here

CardieX subsidiary ATCOR expanded its patent application to cover a system and method for obtaining those same heart and arterial health indicators from PPG sensors in a multitude of electronic devices including laptops and computer ID sensors, mouse devices, computer gaming controls, and keyboards. The company currently holds more than 14 patents in blood pressure and wearable sensor technologies which are being built into new CONNEQT devices.

We’d love to hear from you

CardieX is a global health technology company. Its ATCOR division is the world leader in medical devices and digital solutions for hypertension, cardiovascular disease, and other vascular health disorders. Its CONNEQT subsidiary develops and markets consumer home health devices and wearables. CardieX is listed on the Australian Stock Exchange (ASX:CDX).